Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID‐19 patients

BACKGROUND: Coronavirus disease‐2019 (COVID‐19) has been associated with cutaneous findings, some being the result of drug hypersensitivity reactions such as maculopapular drug rashes (MDR). The aim of this study was to investigate whether COVID‐19 may impact the development of the MDR. METHODS: Blo...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitamura, Yasutaka, Schulz, Daniel, Oro, Saskia, Li, Nick, Kolm, Isabel, Lang, Claudia, Ziadlou, Reihane, Tan, Ge, Bodenmiller, Bernd, Steiger, Peter, Marzano, Angelo, de Prost, Nicolas, Caudin, Olivier, Levesque, Mitchell, Stoffel, Corinne, Schmid‐Grendelmeier, Peter, Maverakis, Emanual, Akdis, Cezmi A., Brüggen, Marie‐Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441838/
https://www.ncbi.nlm.nih.gov/pubmed/34157151
http://dx.doi.org/10.1111/all.14983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441838/
https://www.ncbi.nlm.nih.gov/pubmed/34157151
http://dx.doi.org/10.1111/all.14983

Ejemplares similares